Alison Luckey

3.8k total citations
6 papers, 27 citations indexed

About

Alison Luckey is a scholar working on Epidemiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Alison Luckey has authored 6 papers receiving a total of 27 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Epidemiology, 1 paper in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in Alison Luckey's work include Ethics in Clinical Research (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Nail Diseases and Treatments (1 paper). Alison Luckey is often cited by papers focused on Ethics in Clinical Research (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Nail Diseases and Treatments (1 paper). Alison Luckey collaborates with scholars based in New Zealand, United States and Switzerland. Alison Luckey's co-authors include Michael H. Silverman, Gill Webster, James G. Wright, M. Macpherson, Shampa Das, Lynn McFadyen, Todd Riccobene, Susan Raber, Timothy J. Carrothers and Rujia Xie and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, BMJ Open and European Journal of Clinical Pharmacology.

In The Last Decade

Alison Luckey

5 papers receiving 27 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Luckey New Zealand 3 9 7 7 6 6 6 27
Geórgia de Carvalho Braga Brazil 4 2 0.3× 5 0.7× 8 1.3× 6 1.0× 12 29
Rémi Trusson France 4 2 0.3× 12 1.7× 3 0.5× 4 0.7× 7 33
F. Mougel France 3 4 0.6× 9 1.3× 12 2.0× 5 0.8× 3 34
Julián C. Riaño-Moreno Colombia 4 4 0.4× 2 0.3× 3 0.5× 3 0.5× 10 28
K Sato Japan 4 3 0.3× 3 0.4× 2 0.3× 21 3.5× 4 0.7× 7 32
Kate F. Cook United Kingdom 3 6 0.7× 2 0.3× 2 0.3× 21 3.5× 1 0.2× 8 36
K. Norman United States 3 2 0.3× 3 0.4× 2 0.3× 5 0.8× 4 26
Xavier Molero Spain 2 6 0.9× 6 0.9× 2 0.3× 8 1.3× 2 33
Can Hou China 3 4 0.6× 3 0.4× 7 1.2× 2 0.3× 9 16
Heleen Verschueren Netherlands 2 1 0.1× 4 0.6× 5 0.7× 5 0.8× 2 0.3× 3 14

Countries citing papers authored by Alison Luckey

Since Specialization
Citations

This map shows the geographic impact of Alison Luckey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Luckey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Luckey more than expected).

Fields of papers citing papers by Alison Luckey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Luckey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Luckey. The network helps show where Alison Luckey may publish in the future.

Co-authorship network of co-authors of Alison Luckey

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Luckey. A scholar is included among the top collaborators of Alison Luckey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Luckey. Alison Luckey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Bhavnani, Sujata M., Jeffrey Hammel, Alison Luckey, et al.. (2025). P-1251. Pharmacometric Analyses to Support Dose Selection of Zoliflodacin, a First-in-Class Oral Antibiotic Being Developed for the Treatment of Uncomplicated Gonorrhea. Open Forum Infectious Diseases. 12(Supplement_1).
2.
Das, Shampa, Todd Riccobene, Timothy J. Carrothers, et al.. (2024). Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation. European Journal of Clinical Pharmacology. 80(4). 529–543. 11 indexed citations
3.
Luckey, Alison, Emilie Alirol, Sophie Delhomme, et al.. (2023). Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open‐label randomized cross‐over study in healthy subjects. Clinical and Translational Science. 16(5). 770–780. 3 indexed citations
4.
Jiménez-Rodríguez, Rosa M., Guillermo Martín-Gutiérrez, Silvia Jiménez‐Jorge, et al.. (2022). Factors associated with recruitment success in the phase 2a study of aztreonam–avibactam development programme: a descriptive qualitative analysis among sites in Spain. BMJ Open. 12(2). e051187–e051187. 2 indexed citations
5.
Luckey, Alison, et al.. (2015). Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 1. 2450003353–2450003353. 10 indexed citations
6.
Molfino, Néstor A., Philip G. Bardin, Philip J. Thompson, Alison Luckey, & Geoffrey Yarranton. (2013). A Randomized Placebo-Controlled Safety and Pharmacodynamic Study of KB002, a Chimeric Anti-GM-CSF Monoclonal Antibody, in Patients with Asthma. Journal of Allergy and Clinical Immunology. 131(2). AB229–AB229. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026